Three Questions with Sedgwick’s Jeremy Schutz
December 4, 2024Cybersecurity, Privacy & Data Protection, Medical Devices, Health Care, Artificial Intelligence, Health Information Privacy & Security, Food and Drug Administration (FDA), AI/ML Devices, Supply Chain , FDA Enforcement, Enforcement
In this edition of Three Questions, health care & life sciences partner Nate Brown spoke with Jeremy Schutz, director of business development, recall & remediation at Sedgwick, to explore key strategies that pharmaceutical companies and medical device manufacturers can adopt to mitigate risks related to supply chain disruptions, cybersecurity threats and increased FDA enforcement of quality control and compliance.
Get the latest FDA and related regulatory developments critical to the life sciences industry delivered to your inbox.
